Quantification of mRNA Decay Rates in HeLa and SH-SY5Y Cell Lines Reveals Novel Properties of Membrane Protein Coding Transcripts
Nucleic Acid Therapeutics · 2025
DOI: 10.1177/21593337251377561 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acid Therapeutics, 2025. Verfasst von Melanie B Martinez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Eli Lilly and Company, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: RNA Stability, RNA, Messenger, Membrane Proteins. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Posttranscriptional regulation is crucial for siRNA design, as decay rates in cell lines influence perceived siRNA potency. This study profiles transcripts with 'fast' and 'slow' half-lives in HeLa and SH-SY5Y cells, commonly used in drug discovery. We calculated half-lives for 1,815 HeLa and 5,376 SH-SY5Y transcripts, finding comparable half-lives between cell lines, though HeLa cells generally had longer half-lives. Comparing mRNA and protein half-lives, 'fast' decay transcripts encoded proteins with shorter half-lives, while 'slow' decay transcripts encoded stable proteins. We linked mRNA decay rates to siRNA activity by comparing HeLa data to a previous siRNA screen, discovering that faster decay transcripts had lower knockdown. Surprisingly, stable transcripts, more amenable to knockdown, were over-represented by membrane protein-coding transcripts. Despite their stability, these transcripts had low-to-moderate expression, regardless of miRNA regulation. We explored cis- and trans- features affecting mRNA stability and expression, suggesting that low RNA binding protein (RBP) binding, combined with specific stabilizing RBP regulation, contributes to the stability of these membrane protein-coding transcripts. This study highlights the importance of understanding transcript features, mRNA decay and its potential impact on siRNA efficacy, particularly for transcripts encoding membrane proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eli Lilly and Company, Indianapolis, Indiana, USA.
ORCID-Profile: Pooja Gangras
Zitieren
APA
Martinez, M. B., Williamson, C. J., Cazares, T., Tang, C., Debets, M. F., & Gangras, P. (2025). Quantification of mRNA Decay Rates in HeLa and SH-SY5Y Cell Lines Reveals Novel Properties of Membrane Protein Coding Transcripts. Nucleic Acid Therapeutics. https://doi.org/10.1177/21593337251377561
Vancouver
Martinez MB, Williamson CJ, Cazares T, Tang C, Debets MF, Gangras P. Quantification of mRNA Decay Rates in HeLa and SH-SY5Y Cell Lines Reveals Novel Properties of Membrane Protein Coding Transcripts. Nucleic Acid Therapeutics. 2025. doi:10.1177/21593337251377561
BibTeX
@article{Martinez2025,
author = {Martinez, Melanie B and Williamson, Colton J and Cazares, Tareian and Tang, Chunlao and Debets, Marjoke F and Gangras, Pooja},
title = {Quantification of mRNA Decay Rates in HeLa and SH-SY5Y Cell Lines Reveals Novel Properties of Membrane Protein Coding Transcripts},
journal = {Nucleic Acid Therapeutics},
year = {2025},
doi = {10.1177/21593337251377561}
}
EUVIMED